SPL 1.02% 9.9¢ starpharma holdings limited

New indications for irinotecan, page-2

  1. 15,731 Posts.
    lightbulb Created with Sketch. 5757
    Starpharma's Dep Irinotecan combination cancer drug has shown to be superior to Onivyde


    I must have missed those trial results ? Can you provide the link to the human trial and the 'superior results' when the two drugs (DEP Irinotecan and Onivyde) were compared in a trial setting ? ..... otherwise your claims are nothing but unsubstantiated nonsense
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.001(1.02%)
Mkt cap ! $41.39M
Open High Low Value Volume
9.8¢ 10.0¢ 9.8¢ $28.58K 288.8K

Buyers (Bids)

No. Vol. Price($)
1 59999 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 1252 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.